Long-term Clinical Outcomes and Correlative Efficacy Analyses in Patients (Pts) With Relapsed/Refractory (r/r) Follicular Lymphoma (FL) Treated With Tisagenlecleucel in the ELARA Trial

被引：0

作者：

Dreyling, M. ^{[1
]}

Dickinson, M. ^{[2
,3
]}

Martinez-Lopez, J. ^{[4
]}

Kolstad, A. ^{[5
]}

Butler, J. ^{[6
]}

Ghosh, M. ^{[7
]}

Popplewell, L. ^{[8
]}

Chavez, J. C. ^{[9
]}

Bachy, E. ^{[10
,11
]}

Kato, K. ^{[12
]}

Harigae, H. ^{[13
]}

Kersten, M. J. ^{[14
]}

Andreadis, C. ^{[15
]}

Riedell, P. A. ^{[16
]}

Ho, P. J. ^{[17
,18
]}

Perez-Simon, J. A. ^{[19
]}

Chen, A. I. ^{[20
]}

Nastoupil, L. J. ^{[21
]}

Tresckow, B. V. ^{[22
,23
,24
]}

Ferreri, Maria A. J. ^{[25
]}

Teshima, T. ^{[26
]}

Patten, P. E. ^{[27
,28
]}

McGuirk, J. P. ^{[29
]}

Petzer, A. ^{[30
]}

Offner, F. ^{[31
]}

Viardot, A. ^{[32
]}

Zinzani, P. L. ^{[33
,34
]}

Malladi, R. ^{[35
]}

Paule, I. ^{[36
]}

Zia, A. ^{[36
]}

Awasthi, R. ^{[37
]}

Han, X. ^{[38
]}

Germano, D. ^{[36
]}

O'Donovan, D. ^{[39
]}

Ramos, R. ^{[38
]}

Masood, A. ^{[38
]}

Thieblemont, C. ^{[40
]}

Fowler, N. ^{[41
,42
]}

Schuster, S. J. ^{[43
]}

机构：

[1] LMU Klinikum, Med Klin 3, Munich, Germany

[2] Univ Melbourne, Royal Melbourne Hosp, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[3] Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia

[4] Univ Complutense, Hosp 12 Octubre, Madrid, Spain

[5] Oslo Univ Hosp, Oslo, Norway

[6] Royal Brisbane Hosp, Herston, Qld, Australia

[7] Univ Michigan, Michigan Med, Ann Arbor, MI 48109 USA

[8] City Hope Comprehens Canc Ctr, Duarte, CA USA

[9] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematologyy, Tampa, FL USA

[10] Hosp Civils Lyon, Lyon, France

[11] Univ Claude Bernard Lyon 1, Lyon, France

[12] Kyushu Univ Hosp, Dept Hematol Oncol & Cardiovasc Med, Fukuoka, Fukuoka, Japan

[13] Tohoku Univ Hosp, Sendai, Miyagi, Japan

[14] Univ Amsterdam, Dept Hematol, Ctr Canc, Amsterdam UMC, Amsterdam, Netherlands

[15] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA

[16] Univ Chicago, Med Ctr, Chicago, IL 60637 USA

[17] Royal Prince Alfred Hosp, Camperdown, NSW, Australia

[18] Univ Sydney, Camperdown, NSW, Australia

[19] Univ Seville, Inst Biomed Sevilla, Univ Hosp Virgen Rocio, Dept Hematol, Seville, Spain

[20] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[21] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA

[22] Univ Cologne, Med Fac, Dept Internal Med 1, Cologne, Germany

[23] Univ Cologne, Dept Internal Med 1, Univ Hosp Cologne, Cologne, Germany

[24] Univ Duisburg Essen, Univ Hosp Essen, Dept Hematol & Stem Cell Transplantat, West German Canc Ctr, Essen, Germany

[25] IRCCS San Raffaele Sci Inst, Lymphoma Unit, Milan, Italy

[26] Hokkaido Univ Hosp, Dept Hematol, Sapporo, Hokkaido, Japan

[27] Kings Coll London, Ctr Comprehens Canc, London, England

[28] Kings Coll Hosp London, Dept Haematol, London, England

[29] Univ Kansas Hosp & Med Ctr, Div Hematol Malignancies & Cellular Therapeut, Westwood, KS USA

[30] Ordensklinikum Linz, Internal Med Hematol Stem Cell Transplantat 1, Hemostaseol & Med Oncol, Barmherzige Schwestern Elisabethinen, Linz, Austria

[31] UZ Gent, Ghent, Belgium

[32] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany

[33] IRCCS Azienda Ospedaliero Univ Bologna, Ist Ematol Seragnoli, Bologna, Italy

[34] Univ Bologna, Dipartimento Med Specialist Diagnost & Sperimenta, Bologna, Italy

[35] Cambridge Univ Hosp NHS Fdn Trust, Basel, Switzerland

[36] Novartis Pharma AG, Basel, Switzerland

[37] Novartis Inst BioMed Res, E Hanover, NJ USA

[38] Novartis Pharmaceut, E Hanover, NJ USA

[39] Novartis Pharmaceut, Dublin, Ireland

[40] Hop St Louis, Paris, France

[41] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[42] BostonGene, Waltham, MA USA

[43] Univ Penn, Lymphoma Program, Abramson Canc Ctr, Philadelphia, PA 19104 USA

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1085

引用

页码：306 / 308

页数：3

共 50 条

[1] Long-Term Clinical Outcomes and Correlative Efficacy Analyses in Patients (Pts) with Relapsed/Refractory Follicular Lymphoma (r/r FL) Treated with Tisagenlecleucel in the Elara Trial
Dreyling, Martin
Dickinson, Michael
Martinez Lopez, Joaquin
Kolstad, Arne
Butler, Jason P.
Ghosh, Monalisa
Popplewell, Leslie L.
Chavez, Julio
Bachy, Emmanuel
Kato, Koji
Harigae, Hideo
Kersten, Marie Jose
Andreadis, Charalambos
Riedell, Peter A.
Ho, Phoebe Joy
Perez-Simon, Jose A.
Chen, Andy
Nastoupil, Loretta J.
von Tresckow, Bastian
Ferreri, Andres J. M.
Teshima, Takanori
Patten, Piers E. M.
McGuirk, Joseph P.
Petzer, Andreas
Offner, Fritz
Viardot, Andreas
Zinzani, Pier Luigi
Malladi, Ram
Paule, Ines
Zia, Aiesha
Awasthi, Rakesh
Han, Xia
Germano, Davide
O'Donovan, Darragh
Ramos, Roberto
Masood, Aisha
Thieblemont, Catherine
Fowler, Nathan H.
Schuster, Stephen J.
BLOOD, 2022, 140 : 1459 - 1463
[2] ELARA Trial Update: Long-Term Clinical Outcomes and Correlative Efficacy Analyses of Tisagenlecleucel in Patients With Relapsed/Refractory Follicular Lymphoma (R/R FL)
Fowler, Nathan
Dreyling, Martin
Dickinson, Michael
Martinez-Lopez, Joaquin
Kolstad, Arne
Butler, Jason
Ghosh, Monalisa
Popplewell, Leslie
Chavez, Julio
Bachy, Emmanuel
Kato, Koji
Harigae, Hideo
Kersten, Marie Jose
Andreadis, Charalambos
Riedell, Peter
Ho, P. Joy
Antonio Perez-Simon, Jose
Chen, Andy
Nastoupil, Loretta
von Tresckow, Bastian
Ferreri, Andres Jose Maria
Teshima, Takanori
Patten, Piers
McGuirk, Joseph
Petzer, Andreas
Offner, Fritz
Viardot, Andreas
Zinzani, Pier
Malladi, Ram
Paule, Ines
Zia, Aiesha
Awasthi, Rakesh
Han, Xia
Germano, Davide
O'Donovan, Darragh
Ramos, Roberto
Masood, Aisha
Thieblemont, Catherine
Schuster, Stephen
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S534 - S535
[3] Primary Analysis of the Phase 2 ELARA Trial: Tisagenlecleucel Efficacy and Safety in Adult Patients with Relapsed/Refractory Follicular Lymphoma (r/r FL)
Schuster, Stephen J.
Dickinson, Michael
Dreyling, Martin
Martinez-Lopez, Joaquin
Kolstad, Arne
Butler, Jason
Ghosh, Monalisa
Popplewell, Leslie
Chavez, Julio C.
Bachy, Emmanuel
Kato, Koji
Harigae, Hideo
Kersten, Marie Jose
Andreadis, Charalambos
Riedell, Peter
Zia, Aiesha
Morisse, Mony Chenda
Fowler, Nathan Hale
Thieblemont, Catherine
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S403 - S404
[4] Efficacy and safety of Tisagenlecleucel (Tisa-cel) in adult patients (Pts) with relapsed/refractory follicular lymphoma (r/r FL): Primary analysis of the phase 2 ELARA trial
Schuster, S.
Dickinson, M.
Dreyling, M.
Martinez-Lopez, J.
Kolstad, A.
Butler, J.
Ghosh, M.
Popplewell, L.
Chavez, J.
Bachy, E.
Kato, K.
Harigae, H.
Kersten, M. J.
Andreadis, C.
Riedell, P.
Zia, A.
Morisse, M. C.
Fowler, N. H.
Thieblemont, C.
ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 104 - 105
[5] Clinical Outcomes of Patients With Relapsed/Refractory Follicular Lymphoma (R/R FL) Treated With Tisagenlecleucel: Phase 2 ELARA 3-Year Follow-Up
Schuster, Stephen J.
Fowler, Nathan Hale
Dickinson, Michael
Martinez-Lopez, Joaquin
Kolstad, Arne
Butler, Jason
Ghosh, Monalisa
Popplewell, Leslie
Chavez, Julio C.
Bachy, Emmanuel
Kato, Koji
Harigae, Hideo
Kersten, Marie Jose
Andreadis, Charalambos
Riedell, Peter A.
Ho, P. Joy
Perez-Simon, Jose Antonio
Chen, Andy I.
Nastoupil, Loretta J.
von Tresckow, Bastian
Ferreri, Andres Jose Maria
Teshima, Takanori
Patten, Piers E. M.
McGuirk, Joseph P.
Petzer, Andreas L.
Offner, Fritz
Viardot, Andreas
Zinzani, Pier Luigi
Malladi, Ram
Zia, Aiesha
Awasthi, Rakesh
Paule, Ines
Germano, Davide
Ramos, Roberto
Hsu, Pei
Thieblemont, Catherine
Dreyling, Martin
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S495 - S496
[6] Efficacy of Tisagenlecleucel in Adult Patients (Pts) with High-Risk Relapsed/Refractory Follicular Lymphoma (r/r FL): Subgroup Analysis of the Phase II Elara Study
Thieblemont, Catherine
Dickinson, Michael
Martinez-Lopez, Joaquin
Kolstad, Arne
Butler, Jason P.
Ghosh, Monalisa
Popplewell, Leslie L.
Chavez, Julio C.
Bachy, Emmanuel
Kato, Koji
Harigae, Hideo
Kersten, Marie Jose
Andreadis, Charalambos
Riedell, Peter A.
Ho, P. Joy
Perez-Simon, Jose
Chen, Andy
Nastoupil, Loretta
Von Tresckow, Bastian
Ferreri, Andres J. M.
Teshima, Takanori
Patten, Piers E. M.
McGuirk, Joseph P.
Petzer, Andreas
Offner, Fritz
Viardot, Andreas
Zinzani, Pier Luigi
Malladi, Ram
Zia, Aiesha
Bodoni, C. Lobetti
Masood, Aisha
Schuster, Stephen J.
Fowler, Nathan H.
Dreyling, Martin H.
BLOOD, 2021, 138
[7] Efficacy and safety of tisagenlecleucel (Tisa-cel) in adult patients (Pts) with relapsed/refractory follicular lymphoma (r/r FL): Primary analysis of the phase 2 Elara trial.
Schuster, Stephen J.
Dickinson, Michael J.
Dreyling, Martin H.
Martinez, Joaquin
Kolstad, Arne
Butler, Jason Paul
Ghosh, Monalisa
Popplewell, Leslie
Chavez, Julio C.
Bachy, Emmanuel
Kato, Koji
Harigae, Hideo
Kersten, Marie Jose
Andreadis, Charalambos
Riedell, Peter A.
Abdelhady, Ahmed M.
Zia, Aiesha
Morisse, Mony Chenda
Fowler, Nathan Hale
Thieblemont, Catherine
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[8] Long-term follow-up of patients (pts) with relapsed or refractory (r/r) follicular lymphoma (FL) treated with copanlisib.
Leppa, Sirpa
Santoro, Armando
Demeter, Judit
Follows, George
Lenz, Georg
Kim, Won Seog
Mollica, Luigina
Nagler, Arnon
Diong, Colin Phipps
Provencio, Mariano
Stevens, Don A.
Trevarthen, David R.
Wang, MingLu
Wirtz, Oliver
Miriyala, Ashok
Vargas, Jose Garcia
Childs, Barrett H.
Zinzani, Pier Luigi
Dreyling, Martin H.
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[9] ELARA: A phase II, single-arm, multicenter, open label trial investigating the efficacy and safety of tisagenlecleucel in adult patients with refractory/relapsed follicular lymphoma (r/r FL).
Dickinson, Michael
Popplewell, Leslie
Kolstad, Arne
Ho, Joy
Teshima, Takanori
Dreyling, Martin H.
Schuster, Stephen J.
Thieblemont, Catherine
Yateman, Nigel
Lehnhoff, Katja
Lawniczek, Tomasz
Bubuteishvili-Pacaud, Lida
Fowler, Nathan Hale
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[10] Matching-Adjusted Indirect Comparison (MAIC) of efficacy and safety for tisagenlecleucel and mosunetuzumab in patients (pts) with Relapsed/Refractory (r/r) Follicular Lymphoma (FL)
Dreyling, M.
Fowler, N.
Schuster, S.
Yang, H.
Xiang, C.
Ramos, R.
Maier, H.
Jousseaume, E.
Thieblemont, C.
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 50 - 51

← 1 2 3 4 5 →